Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,103,181
-$171,755 QoQ
Shares Held
16,647
+2.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#815
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026E&G Advisors, LP holds $9,382,400 across 9 Drug Manufacturers - General names. GILD ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,773 | $2,126,589 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
16,647 | $2,103,181 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,325 | $1,840,762 | |
| 4 | ABBV |
AbbVie Inc.
|
3,609 | $908,168 | |
| 5 | NVS |
Novartis AG
|
5,127 | $803,503 | |
| 6 | AMGN |
Amgen Inc
|
2,166 | $784,351 | |
| 7 | AZN |
Astrazeneca PLC
|
1,541 | $292,204 | |
| 8 | SNY |
Sanofi
|
6,398 | $272,938 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,103,181 | 16,647 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,274,936 | 16,323 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,011,585 | 16,389 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,841,379 | 16,589 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,838,446 | 16,582 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,950,006 | 17,403 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,609,916 | 17,429 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,494,783 | 17,829 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,223,247 | 17,829 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,305,974 | 17,829 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,444,327 | 17,829 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,403,551 | 18,729 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,471,189 | 19,089 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,583,814 | 19,089 | Shares | Sole | 2023-07-20 | |
| 2022-12-31 | $1,674,847 | 19,509 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,302,214 | 21,109 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,341,833 | 21,709 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $1,290,600 | 21,709 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $1,554,507 | 21,409 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $1,495,418 | 21,409 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $1,481,000 | 0 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,377,200 | 21,309 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $1,263,251 | 21,683 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,351,191 | 21,383 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,787,700 | 23,235 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $1,737,048 | 23,235 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||